| As Campbell asked, why has it been left to Danish researchers (who were doing Hepatitis C testing and decided to tack on an assay for covid jab mod-spike mRNA) to look into these questions? Why haven't Moderna or Pfizer undertaken large-scale studies of this type? Why haven't they been mandated by large regulatory agencies in the USA, UK, et al.; Japan; etc.? Why haven't well-funded researchers in those nations done similar work? We're so far downstream from the initial rollout that nobody seems to recall the blanket assurances that all of the mRNA in the shots would be taken up and translated into modified spike proteins in a very short period given by health authorities and putative experts during the height of the coercion campaigns. It's much the same as with the issue of biodistribution. Most have forgotten why we were promised the contents of one of these shots remained at the injection site and how the practice of aspiration of the needle (done in Denmark, after concerns were raised, but rarely done elsewhere) was pooh-poohed. The same individuals and entities preached the stays-in-the-arm gospel and derided anyone who raised concern or produced research results indicating wider distribution, via the vasculature, throughout recipients' bodies. The same people who promulgate the idea that VAERS and the Yellow Card system and analogous institutions are now honeypots for fake reports from Russian bots or the "Science Truster' bogeyman du jour. Oh well. Spilled milk at this point. The revelations will continue to trickle out for the foreseeable future. Turnover in the upper echelons of regulatory and funding bodies and in academic biomed research will gradually loosen more tongues. Eventually, there may be large lawsuits and settlements. We will see. |
I imagine to know something like that would be useful for later itterarations or variations of mRNA applications?